Severe Autoinflammatory Manifestations and Antibody Deficiency Due to Novel Hypermorphic PLCG2 Mutations. (2020)
Attributed to:
Assessing new therapeutic opportunities linked to TCR signalling in mature T-cell lymphomas with unmet need
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s10875-020-00794-7
PubMed Identifier: 32671674
Publication URI: http://europepmc.org/abstract/MED/32671674
Type: Journal Article/Review
Volume: 40
Parent Publication: Journal of clinical immunology
Issue: 7
ISSN: 0271-9142